Clinical trial
Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients
NCT00319189 · University of Oslo School of Pharmacy, Other · Completed
Key facts
| NCT number | NCT00319189 |
|---|---|
| Title | Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients |
| Official title | Efficacy and Safety of Nateglinide Treatment in Renal Treatment Recipients With Post Transplant Diabetes Mellitus or Impaired Glucose Tolerance |
| Lead sponsor | University of Oslo School of Pharmacy, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Renal Transplant Recipients, Posttransplant Diabetes Mellitus, Posttransplant Impaired Glucose Tolerance |
| Intervention type | Drug |
| Interventions | Nateglinide |
| Enrollment | 15 |
| Start date | Nov 1, 2002 |
| Completion | Nov 1, 2003 |
| First posted | Apr 27, 2006 |
| Last update posted | May 10, 2006 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: